HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuewu Tang Selected Research

Therapeutics

12/2021An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuewu Tang Research Topics

Disease

4Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2019
3Neoplasms (Cancer)
10/2023 - 12/2021
1Glioma (Gliomas)
01/2024
1Non-alcoholic Fatty Liver Disease
11/2023
1Carcinogenesis
12/2021
1Carcinoma (Carcinomatosis)
09/2021
1Liver Failure
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Liver Neoplasms (Liver Cancer)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
01/2024
1N-methyladenosineIBA
10/2023
1Epithelial Cell Adhesion MoleculeIBA
10/2023
1MicroRNAs (MicroRNA)IBA
10/2023
1Glutamine (L-Glutamine)FDA Link
12/2021
1RNA (Ribonucleic Acid)IBA
12/2021
13' Untranslated Regions (3' UTR)IBA
12/2021
1HMGB1 Protein (HMG1)IBA
12/2021
1CateninsIBA
09/2021
1AlbuminsIBA
01/2021
1BilirubinIBA
01/2021
1NSC 74859IBA
01/2019
1Delta CateninIBA
01/2019

Therapy/Procedure

2Immunotherapy
01/2024 - 12/2021
2Hepatectomy
11/2023 - 01/2021
1Therapeutics
12/2021